Home  »  Science   »  Tonix Pharmaceuticals Holding Corp. (TNXP) Falls -...

Tonix Pharmaceuticals Holding Corp. (TNXP) Falls -3.25%, Causing Bears To Lose

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has a beta value of 1.71 and has seen 4.53 million shares traded in the last trading session. The company, currently valued at $65.69M, closed the last trade at $1.19 per share which meant it lost -$0.04 on the day or -3.25% during that session. The TNXP stock price is -868.07% off its 52-week high price of $11.52 and 75.63% above the 52-week low of $0.29. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.44 million shares traded. The 3-month trading volume is 6.65 million shares.

The consensus among analysts is that Tonix Pharmaceuticals Holding Corp. (TNXP) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$1.02.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) trade information

Sporting -3.25% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 01/23/23 when the TNXP stock price touched $1.19 or saw a rise of 16.78%. Year-to-date, Tonix Pharmaceuticals Holding Corp. shares have moved 205.28%, while the 5-day performance has seen it change -8.46%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) have changed 283.87%. Short interest in the company has seen 1.13 million shares shorted with days to cover at 0.53.

Wall Street analysts have a consensus price target for the stock at $6.33, which means that the shares’ value could jump 81.2% from current levels. The projected low price target is $6.00 while the price target rests at a high of $6.50. In that case, then, we find that the current price level is -446.22% off the targeted high while a plunge would see the stock gain -404.2% from current levels.

Tonix Pharmaceuticals Holding Corp. (TNXP) estimates and forecasts

Figures show that Tonix Pharmaceuticals Holding Corp. shares have outperformed across the wider relevant industry. Other than that, the company has, however, increased its growth outlook for the 2023 fiscal year revenue. Growth estimates for the current quarter are 36.30% and 54.50% for the next quarter.

TNXP Dividends

Tonix Pharmaceuticals Holding Corp. is expected to release its next earnings report between March 13 and March 17 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)’s Major holders

Insiders own 0.02% of the company shares, while shares held by institutions stand at 8.44% with a share float percentage of 8.44%. Investors are also buoyed by the number of investors in a company, with Tonix Pharmaceuticals Holding Corp. having a total of 77 institutions that hold shares in the company. The top two institutional holders are Morgan Stanley with over 0.89 million shares worth more than $1.4 million. As of Jun 29, 2022, Morgan Stanley held 1.98% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 0.73 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $1.16 million and represent 1.63% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Jun 29, 2022, the former fund manager holds about 1.20% shares in the company for having 0.54 million shares of worth $0.85 million while later fund manager owns 0.18 million shares of worth $0.29 million as of Jun 29, 2022, which makes it owner of about 0.41% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts